Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
/
Haleon
Create a narrative
Haleon Community
LSE:HLN Community
3
Narratives
written by author
0
Comments
on narratives written by author
49
Fair Values set
on narratives written by author
Community Investing Ideas
Haleon
Popular
Undervalued
Overvalued
Haleon
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Emerging Markets And Digital Channels Will Transform Global Reach
Key Takeaways Expanding presence in emerging markets and leveraging digital channels drives strong brand growth, enhanced revenue prospects, and strategic geographic diversification. Investments in innovation, supply chain efficiencies, and premiumization strengthen long-term market share, margin expansion, and sustainable earnings growth.
View narrative
UK£4.14
FV
20.3% undervalued
intrinsic discount
3.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
23 days ago
author updated this narrative
Haleon
AN
AnalystHighTarget
Community Contributor
Aging Global Demand And Digital Reach Will Drive Consumer Healthcare
Key Takeaways Global expansion, innovation, and strong brand positioning are expected to drive multiyear revenue growth and margin improvement beyond current market expectations. Operational efficiencies, digital strategies, and China integration are likely to enhance profitability, free cash flow, and competitive advantage over the long term.
View narrative
UK£5.03
FV
34.4% undervalued
intrinsic discount
4.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 months ago
author updated this narrative
Haleon
AN
AnalystLowTarget
Community Contributor
Rising Regulatory Costs And Shifting Consumer Preferences Will Undermine Performance
Key Takeaways Rising regulatory costs and evolving health guidelines threaten margins, while core product reformulation may constrain long-term earnings and growth. Shifting consumer preferences and weak innovation expose Haleon to declining demand, competitive pressures, and limited ability to defend its leading brands.
View narrative
UK£3.2
FV
3.1% overvalued
intrinsic discount
2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 months ago
author updated this narrative